Clinical Trials Logo

Smoking Behaviors clinical trials

View clinical trials related to Smoking Behaviors.

Filter by:

NCT ID: NCT06228235 Not yet recruiting - Smoking Behaviors Clinical Trials

rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings

Start date: February 2024
Phase: N/A
Study type: Interventional

The objective of this pilot clinical trial is to test the effects of different types of thinking strategies at the time of repetitive Transcranial Magnetic Stimulation (rTMS), applied to the left Dorsolateral Prefrontal Cortex (DLPFC), on smoking craving and brain activity. Participants will be individuals with moderate to high smoking dependence (smoking at least 8 cigarettes a day) who have no intention of quitting in the next 3 months and are eligible to have rTMS and functional magnetic resonance imaging (fMRI). The main objectives of the trial are: 1. To compare the craving-reducing effects of "upregulation" and "downregulation" of craving while looking at pictures related to cigarette smoking during rTMS versus no regulation of craving while looking at neutral pictures unrelated to smoking. 'Upregulation" is thinking about the immediate positive experience of smoking. "Downregulation" is thinking about the long-term negative consequences of smoking. 2. To examine changes in brain activity that accompany craving reductions produced by rTMS paired with upregulation and downregulation of craving while looking at pictures related to cigarette smoking versus no regulation of craving while looking at neutral pictures unrelated to smoking. Following screening for eligibility, participants will be trained on how to do upregulation and downregulation of craving. The participants will then participate in 3 testing sessions. In each session, the participants will receive rTMS at 20Hz in 50 trains (2000 pulses total), followed immediately by fMRI. Sessions will take place 1-2 weeks apart and will differ in the type of thinking strategy participants will use while looking at pictures during the rTMS: - upregulation of craving while viewing smoking-related images - downregulation of craving while viewing smoking-related images - no regulation of craving while viewing neutral smoking-unrelated images The order of sessions will be randomized across participants.

NCT ID: NCT06191419 Recruiting - Tobacco Smoking Clinical Trials

Human Perception of Odors and Odor Blockers

Start date: January 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to determine whether blockers of perception of key odorants in cigarette smoke have any utility in smoking cessation. The main question it aims to answer is: • Can odor blockers be used to suppress perception of the intensity of cigarette smoke in ways that reduce the ability of the odor of cigarette smoke to increase the urge to smoke. Participants will be asked to smell up to 20 odor samples per session and report on odor pleasantness and desire to smoke.

NCT ID: NCT06118502 Not yet recruiting - Cigarette Smoking Clinical Trials

A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse

ADAPT
Start date: March 2024
Phase: N/A
Study type: Interventional

This is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicline, or a harm reduction product (e-cigarette) for a full 12 weeks. Most participants will receive some combination of these treatments, depending on individual response to each. All visits and study assessments will be entirely remote. All treatments will be provided free of charge for the first 12 weeks. After that, the study team will contact the participants 6 months after the first study phone call to complete another survey. The study lasts six months and will involve 8 surveys.

NCT ID: NCT06077240 Not yet recruiting - Smoking Clinical Trials

Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction

Start date: March 2024
Phase: N/A
Study type: Interventional

The study will recruit an anticipated 256 adults who currently smoke cigarettes and report a willingness to try switching to alternative, non-combustible products. Participants will be randomized to receive either e-cigarettes or nicotine pouches for a duration of 4 weeks and to 1 of 4 possible regulatory scenarios within products where flavor availability is either menthol and tobacco/unflavored available or tobacco/unflavored only available, and nicotine concentration is either higher (5% e-cig, 6mg pouch) or lower (2.4% e-cig, 3mg pouch). Participants will return for bi-weekly research visits (in person or remote videocall) to complete measures for study aims. Participants will complete a final follow-up at Week 6 to assess maintenance of cigarette reduction and willingness to continue using products once they are no longer provided. The investigators expect to observe which products and constituents lead to greater smoking reduction.

NCT ID: NCT05959512 Not yet recruiting - Smoking Behaviors Clinical Trials

Smoking Pattern and Influencing Factors in Hospitalized Patients

Start date: July 19, 2023
Phase:
Study type: Observational

This study examines the smoking patterns and determinants of inpatients who smoke, develops tailored smoking cessation interventions based on their individual needs, and aims to enhance the effectiveness of quitting and lower the likelihood of relapse.

NCT ID: NCT05950074 Active, not recruiting - Alcohol Drinking Clinical Trials

It´s Up To You: Update and Digitalization of a Universal School-based Prevention Intervention for Drug Initiation and Use

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

This non-randomized cluster-controlled trial examines the effectiveness of the digitalized and updated version of the It´s Up To You - program, a universal school-based prevention intervention for drug initiation and use targeting youth aged between 12 and 17 years.

NCT ID: NCT05949034 Completed - Smoking Behaviors Clinical Trials

Effects of E-Cigarettes in Menthol Smokers

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The current laboratory study examines e-cigarette preferences and smoking behaviors in menthol cigarette smokers.

NCT ID: NCT05905666 Completed - Smoking Cessation Clinical Trials

Health Education and Counseling in Smoking Cessation Behavior, Smoking Decisional Balance, and Self-efficacy

Start date: December 29, 2020
Phase: N/A
Study type: Interventional

Most male smokers with coronary heart disease resume smoking after hospital discharge. The main reason for failure to quit smoking is lack of motivation. However, few studies have used individual health education models to explore the effectiveness of smoking cessation according to the stage of change in smoking cessation behavior of patients. The purpose of this study was to examine the effectiveness of health education and counseling on the stages of change, smoking decisional balance, and self-efficacy of smoking cessation in smokers with no intention of quitting.

NCT ID: NCT05799625 Not yet recruiting - Smoking Cessation Clinical Trials

An Interactive Smartphone Application to Motivate Smokers to Quit

StepOne
Start date: February 2024
Phase: N/A
Study type: Interventional

Prospective, randomized, single-blinded, blinded-endpoint trial to determine the impact of a smartphone application-based program to motivate smokers to increase readiness to quit, make quit attempts, and quit smoking.

NCT ID: NCT05790486 Recruiting - Smoking Cessation Clinical Trials

Take A Break - Rural

TABR
Start date: July 11, 2023
Phase: N/A
Study type: Interventional

The study team proposes a multi-level trial to test 1) novel implementation programs in rural counties designed to increase access to 2) recent advances in tobacco control services for people who are not-yet-ready-to-quit smoking. In this field, most trials have focused only on those already ready-to-quit. Thus, the proposed trial addresses an important knowledge gap critical to advance tobacco control in rural areas.